Fixing of coupon rates - Nykredit Realkredit A/S

Udgivet den 19-12-2024  |  kl. 11:49  |  

To Nasdaq Copenhagen

FIXING OF COUPON RATES                                        19 December 2024

Fixing of coupon rates effective from 1 January 2025

Effective from 1 January 2025, the coupon rates of floating-rate bonds issued by Nykredit Realkredit A/S and Totalkredit A/S will be adjusted.

Bonds with semi-annual interest rate fixing
The new coupon rates will apply from 1 January 2025 to 30 June 2025:

Uncapped bonds
DK0009538498, (32H), maturity in 2025, new rate as at 1 January 2025: 2.9369% pa
DK0009541609, (32G), maturity in 2026, new rate as at 1 January 2025: 2.8558% pa
DK0009547218, (32G), maturity in 2028, new rate as at 1 January 2025: 2.8558% pa

Bonds with quarterly interest rate fixing
The new coupon rates will apply from 1 January 2025 to 31 March 2025:

Uncapped bonds
DK0009518896, (32H), maturity in 2027, new rate as at 1 January 2025: 2.9639% pa
DK0009536443, (32H), maturity in 2025, new rate as at 1 January 2025: 2.8017% pa
DK0009536526, (32G), maturity in 2025, new rate as at 1 January 2025: 2.9436% pa
DK0009538225, (32H), maturity in 2025, new rate as at 1 January 2025: 2.9132% pa
DK0009539892, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9436% pa
DK0009539975, (32H), maturity in 2026, new rate as at 1 January 2025: 3.0653% pa
DK0009540049, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9031% pa
DK0009541369, (32H), maturity in 2025, new rate as at 1 January 2025: 2.8625% pa
DK0009541526, (32G), maturity in 2025, new rate as at 1 January 2025: 2.9639% pa
DK0009543142, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9233% pa
DK0009543225, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9132% pa
DK0009543308, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9740% pa
DK0009543498, (32G), maturity in 2026, new rate as at 1 January 2025: 2.9842% pa
DK0009543811, (32H), maturity in 2025, new rate as at 1 January 2025: 2.8625% pa
DK0009545352, (32H), maturity in 2026, new rate as at 1 January 2025: 2.9132% pa
DK0009545436, (32G), maturity in 2026, new rate as at 1 January 2025: 3.0146% pa
DK0009546087, (32H), maturity in 2027, new rate as at 1 January 2025: 2.8625% pa
DK0009546160, (32H), maturity in 2027, new rate as at 1 January 2025: 2.8524% pa
DK0009546244, (32H), maturity in 2027, new rate as at 1 January 2025: 2.8321% pa
DK0009546327, (32G), maturity in 2027, new rate as at 1 January 2025: 2.8929% pa
DK0009547721, (32H), maturity in 2027, new rate as at 1 January 2025: 2.9639% pa
DK0009766446, (49D), maturity in 2038, new rate as at 1 January 2025: 2.7611% pa
DK0009769622, (21E), maturity in 2041, new rate as at 1 January 2025: 2.7611% pa

Questions may be directed to Investor Relations at investor_relations@nykredit.dk or Press Officer Peter Klaaborg, tel +45 44 55 14 94.

Attachment

Fixing of coupon rates - Nykredit Realkredit - 20241219

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed